Promotion of melanoma growth by the metabolic hormone leptin

Oncology Reports

Volumn 23, Issue 4, 2010, Pages 901-907

  Ellerhorst, Julie A ^a   Diwan, A Hafeez ^a   Dang, Shyam M ^a   Uffort, Deon G ^a   Johnson, Marilyn K ^a   Cooke, Carolyn P ^a   Grimm, Elizabeth A ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

Leptin; Melanoma; Metabolic hormones

Indexed keywords

GROWTH FACTOR; LEPTIN; LEPTIN RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE;

ARTICLE; AUTOCRINE EFFECT; CANCER GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; MELANOCYTE; MELANOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

BLOTTING, WESTERN; CELL LINE, TUMOR; CELL PROLIFERATION; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; IMMUNOHISTOCHEMISTRY; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LEPTIN; MELANOMA; MITOGEN-ACTIVATED PROTEIN KINASES; NEVUS; RECEPTORS, LEPTIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SKIN NEOPLASMS;

EID: 77949454010     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or_00000713     Document Type: Article

References (25)

1. Ellerhorst JA, Naderi AA, Johnson MK, Pelletier P, Prieto VG, Diwan AH, Johnson MM, Gunn DC, Yekell S and Grimm EA: Expression of thyrotropin releasing hormone by human melanoma and nevi. Clin Cancer Res 10: 5531-5536, 2004.
2. Ellerhorst JA, Sendi-Naderi A, Johnson MK, Cooke CP, Dang SM and Diwan AH: Human melanoma cells express functional receptors for thyroid stimulating hormone. Endocr Relat Cancer 13: 1269-1277, 2006.
3. Fruhbeck G, Jebb SA and Prentice AM: Leptin: physiology and pathophysiology. Clin Physiol 18: 399-419, 1998.
4. Fruhbeck G: Intracellular signalling pathways activated by leptin. Biochem J 393: 7-20, 2006.
5. Gao J, Tian J, Lv Y, Shi F, Kong F, Shi H and Zhao L: Leptin induces functional activation of cyclooxygenase-2 through JAK2/STAT3, MAPK/ERK, and PI3K/AKT pathways in human endometrial cancer cells. Cancer Sci 100: 389-395, 2009.
6. Cirillo D, Rachiglio AM, la Montagna R, Giordano A and Normanno N: Leptin signaling in breast cancer: an overview. J Cell Biochem 105: 956-964, 2008.
7. Kim JH, Lee SY, Myung SC, Kim YS, Kim TH and Kim MK: Clinical significance of the leptin and leptin receptor expressions in prostate tissues. Asian J Androl 10: 923-928, 2008.
8. Dieudonne MN, Machinal-Quelin F, Serazin-Leroy V, Leneveu MC, Pecquery R and Giudicelli Y: Leptin mediates a proliferative response in human MCF7 breast cancer cells. Biochem Biophys Res Commun 293: 622-628, 2002.
9. Hardwick JCH, van den Brink GR, Offerhaus GJ, van Deventer SJH and Peppelenbosch MP: Leptin is a growth factor for colonic epithelial cells. Gastroenterology 121: 79-90, 2001.
10. Uffort DG, Grimm EA and Ellerhorst JA: NF-kappaB mediates mitogen-activated protein kinase pathway-dependent iNOS expression in human melanoma. J Invest Dermatol 129: 148-154, 2009.
11. Diwan AH, Dang SM, Prieto VG and Ellerhorst JA: Lack of maturation with anti-leptin receptor antibody in melanoma but not nevi. Mod Pathol 22: 103-106, 2009.
12. Lago R, Gomez R, Lago F, Gomez-Reino J and Gualillo O: Leptin beyond body weight regulation: current concepts concerning its role in immune function and inflammation. Cell Immunol 252: 139-145, 2008.
13. Ekmekcioglu S, Ellerhorst JA, Prieto VG, Johnson MM, Broemeling L and Grimm E: Tumor inducible nitric oxide synthase (iNOS) predicts survival in stage III melanoma. Int J Cancer 119: 861-866, 2006.
14. Salvucci O, Carsana M, Bersani I, Tragni G and Anichini A: Antiapoptotic role of endogenous nitric oxide in human melanoma cells. Cancer Res 61: 318-326, 2001.
15. Rodriguez A, Fortuno A, Gomez-Ambrosi J, Zalba G, Diez J and Fruhbeck G: The inhibitory effect of leptin on angiotensin II-induced vasoconstriction in vascular smooth muscle cells is mediated via a nitric oxide-dependent mechanism. Endocrinology 148: 324-331, 2007.
16. Raso GM, Esposito E, Iacono A, Pacilio M, Coppola A, Bianco G, Diano S, Di Carlo R and Meli R: Leptin induces nitric oxide synthase type II in C6 glioma cells. Role for nuclear factor-κB in hormone effect. Neurosci Lett 396: 121-126, 2006.
17. Fruhbeck G: Pivotal role of nitric oxide in the control of blood pressure after leptin administration. Diabetes 48: 903-908, 1999.
18. Johansson CC, Egyhazi S, Masucci G, Harlin H, Mougiakakos D, Poschke I, Nilsson B, Garberg L, Tuominen R, Linden D, Stolt MF, Hansson J and Kiessling R: Prognostic significance of tumor iNOS and COX-2 in stage III malignant cutaneous melanoma. Cancer Immunol Immunother 58: 1085-1094, 2008.
19. Inoue W, Poole S, Bristow AF and Luheshi GN: Leptin induces cyclooxygenase-2 via an interaction with interleukin-1 beta in the rat brain. Eur J Neurosci 24: 2233-2245, 2006.
20. Ogunwobi O, Mutungi G and Beales IL: Leptin stimulates proliferation and inhibits apoptosis in Barrett's esophageal adenocarcinoma cells by cyclooxygenase-2-dependent, prostaglandin-E2-mediated transactivation of the epidermal growth factor receptor and c-Jun NH2-terminal kinase activation. Endocrinology 147: 4505-4516, 2006.
21. Garofalo C, Koda M, Cascio S, Sulkowska M, Kanczuga-Koda L, Golaszewska J, Russo A, Sulkowski S and Surmacz E: Increased expression of leptin and the leptin receptor as a marker of breast cancer progression: possible role of obesity-related stimuli. Clin Cancer Res 12: 1447-1453, 2006.
22. Revillion F, Charlier M, Lhotellier V, Hornez L, Giard S, Baranzelli MC, Djiane J and Peyrat JP: Messenger RNA expression of leptin and leptin receptors and their prognostic value in 322 human primary breast cancers. Clin Cancer Res 12: 2088-2094, 2006.
23. Stattin P, Soderberg S, Hallmans G, Bylund A, Kaaks R, Stenman UH, Bergh A and Olsson T: Leptin is associated with increased prostate cancer risk: a nested case-referent study. J Clin Endocrinol Metab 86: 1341-1345, 2001.
24. Calle EE, Rodriguez C, Walker-Thurmond K and Thun MJ: Overweight, obesity, and mortality from cancer in a prospectively studied cohort of USA adults. N Engl J Med 348: 1625-1638, 2003.
25. Gogas H, Trakatelli M, Dessypris N, Terzidis A, Katsambas A, Chrousos GP and Petridou ET: Melanoma risk in association with serum leptin levels and lifestyle parameters: a case-control study. Ann Oncol 19: 384-389, 2008.